1. A Benefit–Risk Analysis Approach to Capture Regulatory Decision‐Making: Multiple Myeloma. Issue 1 (20th November 2017) Authors: Raju, G.K.; Gurumurthi, Karthik; Domike, Reuben; Kazandjian, Dickran; Landgren, Ola; Blumenthal, Gideon M.; Farrell, Ann; Pazdur, Richard; Woodcock, Janet Journal: Clinical pharmacology & therapeutics Issue: Volume 103:Issue 1(2018) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A new era of novel immunotherapies for multiple myeloma. Issue 10301 (21st August 2021) Authors: Kazandjian, Dickran; Landgren, Ola Journal: Lancet Issue: Volume 398:Issue 10301(2021) Page Start: 642 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. (10th March 2021) Authors: Kazandjian, Dickran; Dew, Alexander; Hill, Elizabeth; Ramirez, Elizabeth Gil; Morrison, Candis; Mena, Esther; Lindenberg, Liza; Yuan, Constance; Maric, Irina; Wang, Hao‐Wei; Calvo, Katherine; Dulau‐Florea, Alina; Roswarski, Joseph; Emanuel, Michael; Braylan, Raul; Turkbey, Baris; Choyke, Peter; C... Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma. (10th March 2021) Authors: Kazandjian, Dickran; Dew, Alexander; Hill, Elizabeth; Ramirez, Elizabeth Gil; Morrison, Candis; Mena, Esther; Lindenberg, Liza; Yuan, Constance; Maric, Irina; Wang, Hao‐Wei; Calvo, Katherine; Dulau‐Florea, Alina; Roswarski, Joseph; Emanuel, Michael; Braylan, Raul; Turkbey, Baris; Choyke, Peter; C... Journal: Oncologist Issue: Volume 26:Number 4(2021) Page Start: 288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Benefit-Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration-Positive, Metastatic Non-Small Cell Lung Cancer. (21st June 2016) Authors: Kazandjian, Dickran; Blumenthal, Gideon M.; Luo, Lola; He, Kun; Fran, Ingrid; Lemery, Steven; Pazdur, Richard Journal: Oncologist Issue: Volume 21:Number 8(2016) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Benefit‐Risk Summary of Crizotinib for the Treatment of Patients With ROS1 Alteration‐Positive, Metastatic Non‐Small Cell Lung Cancer. (21st June 2016) Authors: Kazandjian, Dickran; Blumenthal, Gideon M.; Luo, Lola; He, Kun; Fran, Ingrid; Lemery, Steven; Pazdur, Richard Journal: Oncologist Issue: Volume 21:Number 8(2016) Page Start: 974 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Clinician Perspectives on Current Issues in Lung Cancer Drug Development. Issue 9 (September 2016) Authors: Waqar, Saiama N.; Bonomi, Philip D.; Govindan, Ramaswamy; Hirsch, Fred R.; Riely, Gregory J.; Papadimitrakopoulou, Vassiliki; Kazandjian, Dickran; Khozin, Sean; Larkins, Erin; Dickson, Dane J.; Malik, Shakun; Horn, Leora; Ferris, Andrea; Shaw, Alice T.; Jänne, Pasi A.; Mok, Tony S.K.; Herbst, Roy... Journal: Journal of thoracic oncology Issue: Volume 11:Issue 9(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma. (November 2018) Authors: Tageja, Nishant; Korde, Neha; Kazandjian, Dickran; Panch, Sandhya; Manasanch, Elisabet; Bhutani, Manisha; Kwok, Mary; Mailankody, Sham; Yuan, Constance; Stetler-Stevenson, Maryalice; Leitman, Susan; Sportes, Claude; Landgren, Ola Journal: Bone marrow transplantation Issue: Volume 53:Number 11(2018) Page Start: 1445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Diagnostic performance of 18F‐FDG‐PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward. (23rd September 2020) Authors: Hill, Elizabeth; Mena, Esther; Morrison, Candis; Dew, Alexander; Choyke, Peter; Lindenberg, Liza; Kazandjian, Dickran Journal: British journal of haematology Issue: Volume 193:Number 1(2021) Page Start: 125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies. Issue 10 (24th August 2022) Authors: Landgren, Ola; Kazandjian, Dickran; Roussel, Murielle; Jasielec, Jagoda; Dytfeld, Dominik; Anderson, Aparna; Kervin, Tara A.; Iskander, Karim; McFadden, Ian; Jakubowiak, Andrzej J. Journal: Leukemia & lymphoma Issue: Volume 63:Issue 10(2022) Page Start: 2413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗